ES528012A0 - Procedimiento de preparacion de un derivado de la benzamida - Google Patents

Procedimiento de preparacion de un derivado de la benzamida

Info

Publication number
ES528012A0
ES528012A0 ES528012A ES528012A ES528012A0 ES 528012 A0 ES528012 A0 ES 528012A0 ES 528012 A ES528012 A ES 528012A ES 528012 A ES528012 A ES 528012A ES 528012 A0 ES528012 A0 ES 528012A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
benzamide derivative
benzamide
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES528012A
Other languages
English (en)
Other versions
ES8505935A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Publication of ES8505935A1 publication Critical patent/ES8505935A1/es
Publication of ES528012A0 publication Critical patent/ES528012A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES528012A 1982-08-24 1983-12-13 Procedimiento de preparacion de un derivado de la benzamida Granted ES528012A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8224296 1982-08-24

Publications (2)

Publication Number Publication Date
ES8505935A1 ES8505935A1 (es) 1985-06-16
ES528012A0 true ES528012A0 (es) 1985-06-16

Family

ID=10532494

Family Applications (2)

Application Number Title Priority Date Filing Date
ES525099A Granted ES525099A0 (es) 1982-08-24 1983-08-23 Procedimiento de preparacion de un derivado de la benzamida
ES528012A Granted ES528012A0 (es) 1982-08-24 1983-12-13 Procedimiento de preparacion de un derivado de la benzamida

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES525099A Granted ES525099A0 (es) 1982-08-24 1983-08-23 Procedimiento de preparacion de un derivado de la benzamida

Country Status (23)

Country Link
US (1) US4507315A (es)
JP (1) JPS5955873A (es)
KR (1) KR840005717A (es)
AT (1) ATA301083A (es)
AU (1) AU1818083A (es)
BE (1) BE897580A (es)
CA (1) CA1195993A (es)
CS (1) CS240973B2 (es)
DE (1) DE3330403A1 (es)
DK (1) DK386783A (es)
ES (2) ES525099A0 (es)
FI (1) FI832989A (es)
FR (1) FR2532310B1 (es)
GB (1) GB2126225B (es)
GR (1) GR78673B (es)
IL (1) IL69544A0 (es)
IT (1) IT1169775B (es)
LU (1) LU84974A1 (es)
NL (1) NL8302947A (es)
NO (1) NO833024L (es)
PT (1) PT77219B (es)
SE (1) SE8304545L (es)
ZA (1) ZA836191B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法
US4916145A (en) * 1987-07-10 1990-04-10 Hoffmann-La Roche Inc. Substituted n-[(pyridyl)alkyl]aryl-carboxamide
US4886629A (en) * 1988-06-06 1989-12-12 Allied-Signal Inc. Process for the preparation of fluorinated benzene sulfonyl fluorides
CA2057324A1 (en) * 1990-12-18 1992-06-19 Lora Louise Fitch Benzamide and sulfonamide hypoglycemic agents
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
WO2001002361A1 (en) * 1999-07-06 2001-01-11 Vertex Pharmaceuticals Incorporated Beta-amino acid derivatives for the treatment of neurological diseases
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
CN101061116A (zh) * 2004-09-24 2007-10-24 詹森药业有限公司 磺酰胺化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3349124A (en) * 1957-05-20 1967-10-24 Pfizer & Co C Oral antidiabetic agent
BE756062A (fr) * 1969-09-11 1971-03-11 Boehringer Sohn Ingelheim Derives de 1,1,1-trichlorethane leurs procedes de fabrication et leur utilisation en tant que substances biocides
DE2500157C2 (de) * 1975-01-03 1983-09-15 Hoechst Ag, 6230 Frankfurt N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
DK148576A (da) * 1975-04-18 1976-10-19 Boehringer Mannheim Gmbh Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling
DE2517229A1 (de) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
US4317915A (en) * 1976-08-23 1982-03-02 Hoffmann-La Roche Inc. Novel thiophene derivatives
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
US4245120A (en) * 1977-09-27 1981-01-13 American Cyanamid Company 4-(Monoalkylamino)benzene polycarboxylic acids
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
KR840005717A (ko) 1984-11-16
ES8505935A1 (es) 1985-06-16
CS612483A2 (en) 1985-06-13
SE8304545D0 (sv) 1983-08-22
JPS5955873A (ja) 1984-03-31
IT1169775B (it) 1987-06-03
ZA836191B (en) 1984-04-25
CS240973B2 (en) 1986-03-13
ATA301083A (de) 1985-11-15
SE8304545L (sv) 1984-02-25
IT8322629A0 (it) 1983-08-24
FR2532310B1 (fr) 1986-01-10
FI832989A (fi) 1984-02-25
DK386783A (da) 1984-02-25
NL8302947A (nl) 1984-03-16
NO833024L (no) 1984-02-24
PT77219B (fr) 1986-02-04
CA1195993A (en) 1985-10-29
GR78673B (es) 1984-09-27
ES8502691A1 (es) 1985-01-16
GB2126225A (en) 1984-03-21
LU84974A1 (fr) 1984-03-23
BE897580A (fr) 1984-02-23
GB8322539D0 (en) 1983-09-21
DK386783D0 (da) 1983-08-23
US4507315A (en) 1985-03-26
ES525099A0 (es) 1985-01-16
FR2532310A1 (fr) 1984-03-02
FI832989A0 (fi) 1983-08-22
AU1818083A (en) 1984-03-01
IL69544A0 (en) 1983-11-30
DE3330403A1 (de) 1984-03-01
PT77219A (fr) 1983-09-01
GB2126225B (en) 1985-10-09

Similar Documents

Publication Publication Date Title
ES530715A0 (es) Un procedimiento de preparacion de un derivado de carbostirilo
ES543047A0 (es) Un procedimiento para preparar un derivado de pirimidina
ES546916A0 (es) Un procedimiento para preparar derivados de guanina
ES532538A0 (es) Un procedimiento para preparar un derivado de carbostirilo
ES538190A0 (es) Un procedimiento para preparar derivados de pirimidina
ES534751A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES534694A0 (es) Un procedimiento para preparar cefuroxima sodica
ES530024A0 (es) Un procedimiento para preparar derivados de pirazinona
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES537668A0 (es) Un procedimiento para preparar n-formil-3-fenoxi-1-azetidincarboxamidas
ES523195A0 (es) Un procedimiento para preparar alquil-glicosidos
ES528304A0 (es) Un procedimiento para preparar derivados de pirimidona
ES534297A0 (es) Un procedimiento para preparar derivados de cefem
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
RO87040A (ro) Procedeu de preparare a n-fosfonometilglicinei
ES531550A0 (es) Procedimiento para preparar un fenilaminobencoalcanol
ES523193A0 (es) Un procedimiento para preparar 3-fenoxi-1-azetidincarbo-xznmidas
ES536050A0 (es) Un procedimiento para preparar fenil-carbamatos sustituidos
ES534170A0 (es) Un procedimiento para preparar 1-piridil-alquil-4-aril-piperazinas
ES545111A0 (es) Un procedimiento para preparar un derivado de fluoralilamina
ES545894A0 (es) Un procedimiento para preparar un derivado de 3-carbonil-1- aminoalquil-1h-indol
ES538072A0 (es) Un procedimiento para preparar un difenil-eter
ES528012A0 (es) Procedimiento de preparacion de un derivado de la benzamida
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona
ES530855A0 (es) Un procedimiento para preparar derivados de benzotiazina